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LAY ABSTRACT
The aim of this review was to evaluate the effective-
ness of neuromuscular electrical stimulation for treating 
oedema, which is the abnormal build up of interstitial 
fluid in the body. A web-based search was performed 
to evaluate clinical trials to assess the effect of neuro-
muscular stimulation within all medical populations. Six 
studies were found that support the use of neuromus-
cular electrical stimulation for reducing oedema and one 
study that did not. These results suggest that neuro-
muscular electrical stimulation may be useful for trea-
ting oedema in both upper and lower limbs. However, 
the findings are limited and further research is needed.
Objective: This systematic review aimed to assess 
the clinical impact of neuromuscular electrical sti-
mulation as a treatment modality for patients with 
oedema. 
Data sources and study selection: PubMed was 
searched up to July 2018 for randomized and non-
randomized clinical trials comparing neuromuscular 
electrical stimulation vs no stimulation following the 
formation of oedema. A modified Downs and Black 
checklist was used to evaluate the quality of the evi-
dence. 
Data synthesis: Initial searches yielded 150 results. 
Removal of duplicates reduced this number to 97 re-
sults. Seventy-five studies were excluded following 
a review of titles and abstracts. Full-text screening 
eliminated 15 studies. A final total of 7 studies met 
the inclusion criteria. Six studies supported the use 
of neuromuscular electrical stimulation for oedema 
reduction, and one study did not find an effect, but 
reported inter-group variance. 
Conclusion: The results of this systematic review 
support the use of neuromuscular electrical stimula-
tion for ameliorating the abnormal accumulation of 
interstitial fluid, which is clinically shown as oede-
ma. Neuromuscular electrical stimulation is effecti-
ve in a number of rehabilitation settings and patient 
groups, for treatment of both upper and lower limb 
oedema. However, further trials are needed to rein-
force these findings. 
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trical stimulation; oedema.
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Oedema may occur following a wide range of musculoskeletal injuries and in other clinical 
settings (1). Following injury an abnormal build-up 
of interstitial fluid in the body can create swelling in 
the affected tissue, causing pain and dysfunction (2). 
Oedema may be generalized, meaning it occurs in 
multiple organs across the body; however, most types 
of oedema are specific to a single organ. Treatment is 
individual to the type of oedema, and in some cases 
the swelling resolves independently. Often, however, 
the treatment of oedema following injury can be chal-
lenging. Treatment of oedema aims to correct the cause 
of the fluid accumulation; however, it can be difficult 
for patients to incorporate traditional management 
strategies (such as rest, ice and elevation) into their 
daily routines. Voluntary activation contractions can 
help to improve circulation by stimulating lymphatic 
flow; however, they are not always possible for a pa-
tient presenting with musculoskeletal injuries and the 
use of compression devices are not always feasible for 
patients with co-morbidities (3).
As well as activation of muscles via the bodies’ 
nervous system, muscles can also be contracted by 
the application of an external electrical stimulation. 
Electro-physical agents have a long-established place 
in therapy practice and the emphasis of this mode of 
treatment has seen significant change over time (4). 
Neuromuscular electrical stimulation (NMES) is the 
elicitation of an involuntary muscle contraction using 
electrical impulses (5). It is proposed that the contrac-
tion of muscles causes intermittent venous compres-
sion and, because of the orientation of the venous 
valves, blood is forced from the periphery, through 
the veins toward the heart. The involuntary muscular 
contraction lowers the mean venous pressure and ser-
ves as an auxiliary pump to assist venous return and 
lymphatic flow, which may reduce oedema. Therefore, 
NMES may affect the lymph drainage or the interstitial 
hydrostatic pressure components of fluid exchange, 
which can affect oedema formation and resolution. 
Devices delivering NMES are wide ranging, and some 
may cause discomfort, therefore such devices are not al-
ways utilized within a clinical setting. In addition, whilst 
increased blood flow is reported to decrease oedema; the 
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All titles and abstracts were initially checked for relevance 
and duplicates by 2 independent reviewers (LB and TW). The 
remaining results then underwent a full-text appraisal to ensure 
that the studies were of good methodological quality, that their 
findings were significant, that they were evaluating a NMES 
device, and that they were examining the effectiveness of the 
device to treat oedema. Study design was assessed using the 
PICO (Patient, Intervention, Comparison and Outcome) fram-
ework to ensure the study was relevant (7). Secondary searching 
was also undertaken, whereby reference lists of the selected 
articles were reviewed for additional studies not identified in 
the primary search.
Quality assessment
The Downs and Black checklist (8) was used to assess the risk 
of bias within the studies sourced. The 27-item methodological 
quality checklist has been shown to have good intra-rater (r. 
0.88) and inter-rater (r. 0.75) reliability (8) It has been used 
previously in systematic reviews with various study designs, 
and has also been amended to suit the structure of the review 
in which it was utilized (9, 10). Similarly, a modified version 
of the Downs and Black checklist was employed with the items 
that were not suitable to the review removed (items 5, 8, 14, 15, 
21–27). The adapted version of the tool consisted of 16 items 
(Appendix 1), including items 1–4, 6, 7, 9–13 and 16–20 from 
the original list, with a maximum possible score of 16. The 
higher scores indicated superior quality. The first 8 items on the 
scale relate to reporting and include aims, outcome measures 
and results. Items 11–13 relate to external validity and consider 
whether results from the study can be generalized to a wider 
population. Items 16–20 relate to internal validity. Risk of bias 
was assessed by 2 independent assessors (LB and TI) and any 
discrepancies were resolved through discussion. 
Statistical analysis 
All of the studies within this review compared pre- and post-
intervention values for oedema size. The majority of the data 
were not normally distributed and, therefore, non-parametric 
testing was used to compare means and variation. Six studies 
also compared between-group changes when electrical stimula-
tion was compared with the following factors: no stimulation, 
placebo stimulation, compression stockings, limb elevation, 
and a whirlpool bath.
outcomes from many individual NMES and oedema stu-
dies remain inconclusive. Thus, the current systematic 
review assessed studies that evaluated NMES devices 
for patients presenting with oedema. The results of this 
review could help the development of rehabilitation 
programmes focused on helping patients with oedema. 
METHODS
Data sources
A systematic review was conducted to examine current publis-
hed evidence regarding the use of NMES for treatment of oede-
ma. The methodology of this review was developed according 
to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement (www.prismastatement.
org/PRISMAStatement) (6). A computer-based search was 
completed in July 2018, and the electronic database sourced 
was PubMed (https://www.ncbi.nlm.nih.gov/pubmed/). The 
search reviewed all fields of the available literature, published 
in the English language (or those for which a translation was 
available) to the earliest record on file. A secondary search was 
also conducted, whereby the reference lists of articles, review 
papers and textbooks were scanned for additional papers. There 
are 2 categories of this type of stimulation, one type of device 
(named NMES) is used to treat muscle atrophy when the muscle 
is in a resting state, and the other, named functional electrical 
stimulation (FES), used to enhance functionality of neurologi-
cally impaired individuals. Therefore, FES search terms were 
also included. Other devices delivering electrical stimulation 
were excluded. Studies were considered eligible for inclusion 
within the synthesis if they met the specified inclusion and 
exclusion criteria listed in Table I.
Study selection
In order to capture studies published across all rehabilitation 
disciplines; a broad search strategy was adopted (Table II). 
Table I. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Population
Any patient population in a rehabilitation 
setting where oedema was treated. 
Studies on animals
Intervention
Neuromuscular electrical stimulation Functional electrical stimulation 
cycling
Functional electrical stimulation Electromyographic biofeedback
Transcutaneous electrical nerve 
stimulation
Calf muscle pump stimulation
Implanted peripheral nerve 
electrodes
Neuromuscular monitoring
High-voltage pulsed current
Outcome measure
Oedema size, or swelling of limb 
Methodology
Randomized clinical trials Review articles
Non-randomized clinical trials of good 
methodological quality
Case studies
Historical studies
Publication
Published in English Unpublished studies
Access to full text Study protocols
Cross-sectional studies
Historical studies
Table II. Search strategy
Search strategy Search terms
1 ((neuromuscular[All Fields] AND (”electric stimulation”[MeSH 
Terms] OR (”electric”[All Fields] AND ”stimulation”[All Fields]) 
OR ”electric stimulation”[All Fields] OR (”electrical”[All Fields] 
AND ”stimulation”[All Fields]) OR ”electrical stimulation”[All 
Fields])) AND (”oedema”[All Fields] OR ”edema”[MeSH 
Terms] OR ”edema”[All Fields])) OR (electrostimulation[All 
Fields] AND (”oedema”[All Fields] OR ”edema”[MeSH Terms] 
OR ”edema”[All Fields]))
2 (neuromuscular[All Fields] AND stimulation[All Fields] 
AND (”oedema”[All Fields] OR ”edema”[MeSH Terms] OR 
”edema”[All Fields]))
3 (electrostimulation[All Fields] AND (”oedema”[All Fields] OR 
”edema”[MeSH Terms] OR ”edema”[All Fields]))
4 (functional[All Fields] AND (”electric stimulation”[MeSH 
Terms] OR (”electric”[All Fields] AND ”stimulation”[All Fields]) 
OR ”electric stimulation”[All Fields] OR (”electrical”[All Fields] 
AND ”stimulation”[All Fields]) OR ”electrical stimulation”[All 
Fields]) AND (”oedema”[All Fields] OR ”edema”[MeSH 
Terms] OR ”edema”[All Fields]))
www.medicaljournals.se/jrm
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RESULTS
A flow diagram of the study identification process is 
shown in Fig. 1 and a summary of the studies sourced 
is shown in Table III. Seven studies assessed the role 
of NMES for reducing oedema (11–17). Oedema size, 
or swelling, was a primary outcome measure in all the 
included studies.
Methodological quality of studies
Appendix 2 presents the results of the methodological 
assessment. Quality assessment scores ranged from 
56% to 88% (mean =77%). Reporting within the stu-
dies was generally consistent. Six studies scored the 
maximum attainable score for clearly describing the 
study aims and objectives (12–17). External validity 
was low scoring, generally due to study participants 
being selected patients, small study size and a lack of 
description of the facility in which the study was un-
dertaken. Internal validity was generally high scoring, 
with 5 studies scoring maximum marks (12, 14–17). 
Marks were lost from 2 studies (11, 13) due to the 
absence of reported patient compliance (item 19). 
Summary of evidence
Lower limb oedema. Five studies assessed the use of 
NMES for reducing oedema in the lower limbs in a 
variety of rehabilitation settings, detailed 
thereafter (11–15). Largely, this evidence 
demonstrates that NMES can reduce 
oedema, although 1 study found no ef-
fect (15); however, the authors attribute 
this to inter-group variance at baseline. 
Other benefits of NMES within current 
literature include improved quality of life 
and reduced pain (11).
Chronic venous oedema/lymphedema. A 
study by Bogachev et al. (11) on patients 
(n = 30, limbs = 32) with chronic evening 
venous oedema found that total or partial 
reduction of oedema occurred in 93.8% 
of limbs with the use of NMES device. 
The circumference of the lower leg di-
minished by 20.3 mm (p < 0.001), pain 
reduced and quality of life improved. 
A more recent randomized clinical trial 
(RCT) by Ravikumar et al. (12) assessed 
the effect of footplate NMES in treating 
patients with venous disease (n = 22). 
Patients were treated with either NMES 
or a sham device daily for 30 min over 
a 6-week period. There was a significant 
difference in the percentage change in the 
femoral vein flow parameters from base-
line between the treatment group and the 
sham group whilst using the device. Limb volume was 
observed to increase significantly in the sham group; 
however, this was prevented in the treatment group, 
demonstrating that NMES can have a preventative role 
in orthostatic limb oedema. 
A pilot interventional crossover study (n = 10) 
by Wou et al. (13) compared 2 NMES devices and 
compression stockings for reducing lower limb oc-
cupational oedema in healthy individuals. Without an 
intervention, leg volume increased by a median of 41 
ml. All devices were well tolerated and reduced leg 
swelling; however, there was no significant effect of 
NMES and the compression stockings were the only 
device that created a significant reduction in swelling. 
Ankle sprain/fracture. A crossover, counterbalance 
trial was completed by Man et al. (14) to evaluate the 
effect of NMES on foot and ankle volume during 30 
min of standing (n = 20). A group of healthy patients 
completed 30 min of standing with and without 
NMES applied to the gastrocnemius and the tibialis 
anterior of the dominant leg, on 2 separate occasions. 
Mean volume changes from pre-test to post-test with 
NMES and without NMES were significantly different 
(p = 0.001). The authors concluded that the activation 
of the musculo-venous pump by a NMES-induced 
muscle contraction may reduce swelling in the lower 
Fig. 1. PRISMA flow diagram.
PRISMA 2009 Flow Diagram 
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DISCUSSION
In medical research, there is an aim to establish the 
lowest dose of medication that is effective in producing 
a clinical benefit with the fewest side-effects possible. 
The discomfort associated with stimulus may reduce 
patient acceptance or compliance with NMES as a 
therapy (18); therefore, it is important that there is a 
balance between effectiveness and comfort, in order to 
promote patient compliance. Technical developments 
of NMES devices have improved patient tolerance by 
allowing effective stimulation with a lower current 
density and pulse duration (18). This may be important 
when comparing the NMES devices that stimulate the 
motor nerve in comparison with those that stimulate 
the motor point. Neural stimulation requires lower 
current intensity for the same level of contraction, and 
thus devices may be better tolerated by patients. The 
use of NMES as a rehabilitative device was reported 
to be feasible and safe in all studies, with no recorded 
harmful side-effects or adverse events.
Within the studies sourced, there is a wide variation 
in the parameters utilized, but, in general, NMES was 
applied for periods of 20–30 min. Stimulation occurred 
once a day in 5 studies (12–15, 17), 5 times per week in 
one study (16), and reduced from 3 times, to 2 times, to 
once per month, in 1 study (11). The majority of studies 
support the use of a higher dose for a short period of 
time, as opposed to a low dose for a long period of time. 
It is important to establish the maximum effect for the 
lowest intensity of stimulation so that the treatment is 
comfortable for the patient. The frequency of applica-
tion and number of repetitions varied between authors, 
with the range between 1 and 125 Hz. A high pulse fre-
quency setting is more commonly used for the treatment 
of pain, and a lower frequency may be advantageous for 
swelling reduction. Duty cycle describes the actual on 
and off time of an NMES programme, and commonly, 
full amplitude “on” period, which is one-third of the 
stimulus “off” time will avoid rapid muscle fatigue. By 
creating non-fatiguing muscle contractions, NMES can 
dilate blood vessels and help to increase blood flow. 
Rehabilitation timing was also non-consistent between 
studies, with treatment commencing at different times in 
each intervention. The percentage change in oedema is 
shown in Table IV; however, variance in methodologies 
prevents detailed a comparison being made. 
Study limitations
Although the variation in patient groups adds genera-
lity to the effectiveness of NMES for reducing oedema, 
limbs of patients by increasing venous return, reducing 
venous stasis, increasing lymph flow, and increasing 
hydrostatic pressure, which would reduce capillary 
filtration and assist fluid absorption. 
A later study by Man and colleagues (15) randomi-
zed 34 patients with an ankle sprain into either: (i) a 
group with NMES applied to the lower leg muscles; (ii) 
a group with sub-motor electrical stimulation applied to 
the lower leg muscles; or (iii) a group with electrodes 
set up on the lower legs with no electrical stimula-
tion applied (sham group). There were no statistically 
significant differences between groups for ankle-foot 
volume and self-assessed ankle function. Ankle girth 
was significantly improved from session 1 to 3 with 
the application of NMES; however, the authors note 
that this result may be confounded due to inter-group 
variance. A statistically significant difference in ankle 
girth measurements was recorded among the 3 groups 
at baseline in addition to an unexpected difference in 
subjects’ height. 
Upper limb oedema. Similar to the results of studies 
assessing NMES for reducing lower limb oedema, 
there are 2 studies that support the feasibility and ef-
fectiveness of NMES for reducing upper limb oedema 
(16–17). Other benefits found were improvements in 
pain, function, range of motion and strength. 
Complex regional pain syndrome. A study by Dev-
rimsel et al. (16) compared the effect of whirlpool 
baths and NMES on complex regional pain syndrome 
(n = 60). The authors found significant improvements 
in pain, oedema, range of motion, fingertip-to-distal 
palmer crease distance, hand grip strength and pinch 
strength in both groups. The efficacy of the whirlpool 
bath treatment was considered more effective due 
to statistically significantly better improvements in 
outcomes; however, both treatments were regarded 
as effective in the treatment of complex regional pain 
syndrome and the reduction of oedema. 
Cerebrovascular accident patients. A small study 
(n = 8) by Faghri (17) used a repeated measure design 
to compare the use of NMES to limb elevation on hand 
oedema patients following a cerebrovascular accident. 
Thirty minutes of NMES of the finger and wrist flexors 
and extensors was compared with the effects of 30 
min of limb elevation alone. The author found both 
treatments to be significantly effective in improving 
volume and girth of the arm and hand, and NMES was 
more effective for the reduction of hand oedema than 
limb elevation within their sample, although no actual 
significance values are reported. 
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it is difficult to compare methodologies from such a 
variety of clinical rehabilitation settings. Increasing 
the number of well-conducted, adequately powered 
RCTs with a standardized methodology would enable 
practitioners to confidently prescribe NMES as a mo-
dality for decreasing oedema. 
In addition, within the study results, there is a wide 
variation within the equipment used to deliver NMES 
to patients. Therefore, it is not easy to advocate the 
use of one NMES device over the other, as there are 
not enough published studies to allow comparative 
analysis. The majority of studies utilized NMES de-
vices that were applied to the skin surface; however, 
2 studies utilized foot-plate NMES (Revitive XI) (12, 
13), which is another methodological variance that 
prevents generality of results. The Revitive IX device 
has a rocker device that elicits active and repetitive 
plantar flexion and dorsiflexion and so whether the ef-
fect is due to limb movement or purely NMES cannot 
be defined. Active plantar flexion and dorsiflexion are 
rehabilitative exercises prescribed to increase lower 
limb blood flow. Thus, reduction in oedema following 
treatment with the Revitive XI device may be attribu-
table to the NMES, the active mobility exercises or a 
combination of both treatments. This has relevance to 
clinical populations where movement is prohibited.
In order to draw a clinically significant conclusion, 
it is important that studies are appropriately powered 
(19). Out of the 7 studies sourced, 2 had fewer than 
12 study participants (13, 17). Although these small 
studies present meaningful results and can assess 
feasibility, their clinical importance is compromised 
due to their underpowered methodologies. Across all 
clinical settings, there is a lack of adequately powered 
RCTs investigating the effect of NMES for oedema. 
Conclusion
Six studies demonstrated that NMES devices are effec-
tive in the treatment or management of oedema, with 
no reported adverse events. There is some evidence, 
Table IV. Percentage change in oedema
Study Device
Oedema 
change
Percentage 
change
Percentage decrease in oedema size (displacement or circumference)
Bogachev et al. (11) Veinoplus –20.3 mm –7.3
Devrimsel et al. (16) Cefar –16.6 ml –49.4
Faghri (17) Medtronic Arm: –32.6 ml/ 
Hand: –13.4 ml
–2.64/ 
–0.53
Man et al. (15) HEALTHFIT –8 ± 65 ml –0.5
Wou et al. (13) Geko
Revititive IX
40.6 ml*
30.7 ml*
–0.06* 
–0.22*
Prevention studies (percentage increase in oedema)
Man et al. (14) HEALTHFIT 12 ± 39 ml 0.8
Ravikumar et al. (12) Revitive IX 176 ml 3.4
*Percentage change relevant to control group.
outlined above, to the effect that NMES activation of 
the venous pumps in the extremities is effective in 
reducing oedema in those extremities, in a variety of 
different patient groups. One study did not find a sig-
nificant clinical effect of NMES in reducing oedema; 
however, the authors recognize that this result may be 
confounded by inter-group variance (15). Appropria-
tely powered clinical trials are required with oedema 
as a primary outcome and a focus on returning to 
function and recovery. Future studies should also aim 
to establish the most effective mode of delivery and 
dose for NMES to facilitate recovery from different 
diseases, procedures or anatomical locations. 
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Appendix 1. Modified Downs and Black Checklist
Modified Downs and Black Checklist for Measuring Study Quality
Reporting
Possible 
answers
1 Is the hypothesis/aim/objective of the study clearly 
described? Yes/No
2 Are the main outcomes to be measured clearly described 
in the Introduction or Methods section? Yes/No
3 Are the characteristics of the patients included in the 
study clearly described? Yes/No
4 Are the interventions of interest clearly described? Yes/No
6 Are the main findings of the study clearly described? Yes/No
7 Does the study provide estimates of the random 
variability in the data for the main outcomes? Yes/No
9 Have the characteristics of patients lost to follow-up been 
described? Yes/No
10 Have actual probability values been reported? Yes/No
External validity 
11 Were the subjects asked to participate in the study 
representative of the entire population from which they 
were recruited? Yes/No/UTD
12 Were those subjects who were prepared to participate 
representative of the entire population from which they 
were recruited? Yes/No/UTD
13 Were the staff, places, and facilities where the patients 
were treated, representative of the treatment the 
majority of patients receive? Yes/No/UTD
Internal validity - bias
16 If any of the results of the study were based on ”data 
dredging”, was this made clear? Yes/No/UTD
17 In trials and cohort studies, do the analyses adjust 
for different lengths of follow-up of patients, or in 
case-control studies, is the time period between the 
intervention and outcome the same for cases and 
controls? Yes/No/UTD
18 Were the statistical tests used to assess the main 
outcomes appropriate? Yes/No/UTD
19 Was compliance with the intervention/s reliable? Yes/No/UTD
20 Were the main outcome measures used accurate (valid 
and reliable)? Yes/No/UTD
UTD: unable to determine. A
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